NCT00696904View on ClinicalTrials.gov

Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

February 28, 2009

Conditions
HCV Infection
Interventions
DRUG

ABT-333

Capsule, see arms for intervention description

DRUG

Placebo

Capsule, see arms for intervention description

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY